Introduction
Epilepsy is a chronic brain disease that can affect the entire population of the world. The prevalence of epilepsy in developed countries is estimated to 5‰ and in Africa 10‰ [1] . However 30% of all patients with epilepsy are estimated to have drug-resistant epilepsy despite a good comprehension of the physiopathological mechanisms and the enrichment of the antiepileptic therapeutic arsenal [2] . It suits to indicate that the adverse effects associated with antiepileptic drugs and recurrent seizures limit their use [3] . Therefore, the search for new therapeutic agents continues, and medicinal plants have emerged as a crucial source for the development of drugs to treat neurological disorders and play an important role for patients who respond poorly to conventional treatments [4. 5]. Crinum scillifolium belongs to the family Amaryllidaceae. In Côte d'Ivoire Crinum scillifolium is found in the southwest and in the center precisely in the clearings of the dense forest. However, there is no pharmacological data on this plant, but the literature indicates that Crinum species due to their traditional uses have also been evaluated biologically [6] . Indeed, most of the species evaluated other than scillifolium showed in vitro, important activities such as, anti-cancer, immunological, antioxidant, analgesic, anti-inflammatory and anticonvulsant. This preliminary study was carried out to evaluate the anticonvulsant activity of aqueous extract of Crinum scillifolium bulbs in mice.
II.
Materials And Methods
Plant material
Bulbs of Crinum Scillifolium were collected from Sikensi, at 80 km to Abidjan. The plant was identified and authenticated by National Center of Floristics, Department of Botany, University Felix Houphouët Boigny.
Preparation of plant extract
After collection, the Bulbs of Crinum scillifolium were washed with distilled water. They were dried under the shade at 23°C and the dried bulbs were ground into fine powder. The powdered material was extracted with distilled water (50 g of powder per 500 ml distilled water) by cold maceration for 48 h with stirring. The extract obtained constitutes the aqueous extract. The macerate was filtered through Whatman filter paper and evaporated to dryness in an oven at a temperature of 45 ° C. The extract was stored in refrigerator (4°C) until ready use. From this various concentration were reconstituted in a known volume of distilled water before administration.
Material animal
Swiss albinos mice (22 -25 g) of either sex were used in this study which were bred in the Laboratory Animal (UFR Pharmaceutical and Biological Sciences; University Félix Houphouët Boigny). The animals were maintained in standard laboratory conditions (25°C) and light/dark cycles, i.e. 12/12h and fed with standard food and water. In all the experimental studies, each group consisted of six animals. Each animal was used only once. The investigation conforms to the recommendation of OECD in 2008 [7] .
Drugs
Isoniazid 100mg® tablet (laboratory LUTIN, India) was used to trigger convulsions and Clonazepam 100mg® tablet (Laboratory La Roche SA, Switzerland) to protect mice from seizures.
Isoniazid-induced seizures
Six groups each of six mice were administered graded doses of aqueous extract of Crinum scillifolium (50, 100, 200 and 400 mg/kg; p.o.), clonazepam (positive control; 3mg/kg) or distilled water (negative control; 10 ml/kg p.o). One hour later, all animals were administered orally with isoniazid (250 mg/kg) and placed in isolated cages [8] . Animals that did not convulse within the 3 hours of observation were qualified as protected. In unprotected animals, the latency to first convulsion, duration of first convulsion, latency of death time, percentage mortality was recorded.
Statistical analysis
The data were analyzed using one-way analysis of variance (ANOVA) followed by Dennett's test using the Graph Pad Prism 4.0 software package. The level of significance was determined in comparison with the control group. Statistical significance was accepted for p< 0.05.
III. Results
As in the INH test, the extract protected animals from INH-induced seizures in dose-dependent manner (Table  I) . Similar to clonazepam, the extract completely inhibited the onset of INH-induced seizures at the 200 mg/kg dose. Moderate protection of 50 % is observed when animals were treated with 50 mg / kg and 83% with 100 and 400 mg / kg doses (Fig 1) . In unprotected animals, the extract at the 100 mg/kg dose demonstrated a significant increase in seizure latency (p<0.05) compared with the control group (Fig 2) . Higher mortality was evident for animals that received distilled water and aqueous extract significantly reduced or prevented the occurrence of death in unprotected animals (Table I) . No dose significantly influenced the time to death in animals compared to mice treated with distilled water (Fig  3) . When mice were treated with 50 mg / kg of Crinum scillifolium extract, a significant increase in the duration of the first crisis was observed (p <0.05) compared to batches treated with distilled water (Fig 4) . No dose significantly influenced the time to death in animals compared to mice treated with distilled water (Fig  3) . When mice were treated with 50 mg / kg of Crinum scillifolium extract, a significant increase in the duration of the first crisis was observed (p <0.05) compared to batches treated with distilled water (Fig 4) . The data were expressed as mean ± S.E.M at risk α = 5%. EA at 100 mg/kg dose significantly increased seizures latency (p <0,05) compared to mice treated with distilled water. n= 6 per dose,* p <0.05 The data analyzed by one-way analysis of variance (ANOVA) followed by Dennett's test. The data were expressed as mean ± S.E.M at risk α = 5%.n= 6 per dose, *** p <0.02. The data analyzed by oneway analysis of variance (ANOVA) followed by Dennett's test. 
IV. Discussion
In the present study, anticonvulsant activity of aqueous extract of Crinum scillifolium bulbs was studied. Isoniazid induced seizures model was used. The convulsions produced by isoniazid is primarily due to inhibition of GABA mediated pathway [9. 10]. It is well documented that INH induced convulsions are produced due to alteration of GABA level in the brain, it reduces the GABA content in the brain by inhibiting glutamic acid decarboxylase (GAD) activity (enzyme responsible for the synthesis of GABA), by combining with pyridoxal phosphate (a coenzyme for its reactions) to form hydrazones and, thus, inhibits the GAD activity [11] .
In this study, orally administration of INH induce severe clonic-tonic convulsion in mice which was reversed by clonazepam and the aqueous extract of Crinum scillifolium bulbs at the 200 mg/kg dose. On the basis of these evidences, it was presumed that the anticonvulsant effect of the aqueous extract might possibly be producing an antiepileptic action by increasing the level of GABA, an inhibitory transmitter in the central nervous systems. The extract enhanced GABA synthesis either by stimulation of L-glutamate or inhibits GABA catabolism by GABA transaminase, leading to an increase in GABA available in the synaptic cleft. 
V. Conclusion
The results of this study showed that the aqueous extract of Crinum scillifolium possess anticonvulsant activity against isoniazid seizures in mice. The present study provides scientific evidence for the use of Crinum scillifolium bulbs in the treatment of epileptic disorders. More studies are necessary to clarify the antiepileptic components and the mechanisms underlying the plant activities.
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